OVERVIEW
The Global Transplant Diagnostics Market is calculated to reach USD 6.43 billion by 2025, growing at a CAGR of 7.13% during the forecast period 2020-2025. The growth witnessed by transplant diagnostics is majorly driven by the increasing public-private funding for target research activities, and growing burden of infectious diseases. Moreover, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics is analyzed to drive the market.
TABLE OF CONTENT
1 Global Transplant Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Transplant Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Transplant Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Transplant Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Transplant Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Transplant Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Transplant Diagnostics Market – By Product (Market Size – & million/billion)
8.1 Reagents and Consumables
8.2 Instruments
8.3 Software and Services
9 Global Transplant Diagnostics Market – By Technology
9.1 Molecular Assays
9.1.1 PCR-Based
9.1.2 Sequencing Based
9.2 Non-Molecular Assays
10 Global Transplant Diagnostics Market – By Application
10.1 Diagnostic Applications
10.2 Research
11 Global Transplant Diagnostics Market – By End-User
11.1 Independent Reference Laboratories
11.2 Hospitals & Transplant Centers
11.3 Research Laboratories & Academic Institutes
12 Global Transplant Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Transplant Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Transplant Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Becton, Dickinson and Company
14.3 Immucor
14.4 Luminex
14.5 Gendx
14.6 Biofortuna
14.7 Merck KGaA
14.8 Omixon
14.9 Bio-Rad Laboratories
14.10 F. Hoffman-La Roche Limited
14.11 Hologic
14.12 Company 11 & more
15 Global Transplant Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations
